Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer A Getz

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
ACS Chemical Biology|May 28, 2011
Protease-resistant peptide ligands from a knottin scaffold libraryJennifer A Getz, Jeffrey J Rice, Patrick S Daugherty
Methods in Enzymology|January 11, 2012
Peptide discovery using bacterial display and flow cytometryJennifer A Getz, Tobias D Schoep, Patrick S Daugherty
Bioanalysis|March 20, 2024
A novel biomarker assay qualification strategy for rare human matrices - a case study of biomarkers in aqueous humorJennifer A Getz, Trung Nguy, Randall Dere, et al.
ACS Chemical Biology|March 30, 2013
Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migrationJennifer A Getz, Olivier Cheneval, David J Craik, et al.
Toxicologic Pathology|November 4, 2022
Neutropenia in Cynomolgus Monkeys With Anti-Drug Antibodies Associated With Administration of Afucosylated Humanized Monoclonal AntibodiesAdeyemi O Adedeji, Fiona Zhong, Jennifer A Getz, et al.
Biological Chemistry|September 5, 2012
Identification of protease exosite-interacting peptides that enhance substrate cleavage kineticsAbeer M Jabaiah, Jennifer A Getz, Witold A Witkowski, et al.
Plos One|November 22, 2013
A novel quantitative kinase assay using bacterial surface display and flow cytometrySónia Troeira Henriques, Louise Thorstholm, Yen-Hua Huang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 29, 2012
Site-specific targeting of antibody activity in vivo mediated by disease-associated proteasesOran Erster, Jerry M Thomas, Juliana Hamzah, et al.
Molecular & Cellular Proteomics : MCP|June 6, 2025
Soluble VCAM-1 May Serve as a Pharmacodynamic CSF Marker to Monitor BACE2 Activity in Non-Human PrimatesSarah K Tschirner, Y Joy Yu Zuchero, Jennifer A Getz, et al.
Toxicology and Applied Pharmacology|January 26, 2024
Nonclinical pharmacokinetics, pharmacodynamics and safety assessment of a FLT3L-Fc molecule for cancer immunotherapyKai Connie Wu, Adeyemi O Adedeji, Tanja S Zabka, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
ACS Chemical Biology|May 28, 2011
Protease-resistant peptide ligands from a knottin scaffold libraryJennifer A Getz, Jeffrey J Rice, Patrick S Daugherty
Methods in Enzymology|January 11, 2012
Peptide discovery using bacterial display and flow cytometryJennifer A Getz, Tobias D Schoep, Patrick S Daugherty
Bioanalysis|March 20, 2024
A novel biomarker assay qualification strategy for rare human matrices - a case study of biomarkers in aqueous humorJennifer A Getz, Trung Nguy, Randall Dere, et al.
ACS Chemical Biology|March 30, 2013
Design of a cyclotide antagonist of neuropilin-1 and -2 that potently inhibits endothelial cell migrationJennifer A Getz, Olivier Cheneval, David J Craik, et al.
Toxicologic Pathology|November 4, 2022
Neutropenia in Cynomolgus Monkeys With Anti-Drug Antibodies Associated With Administration of Afucosylated Humanized Monoclonal AntibodiesAdeyemi O Adedeji, Fiona Zhong, Jennifer A Getz, et al.
Biological Chemistry|September 5, 2012
Identification of protease exosite-interacting peptides that enhance substrate cleavage kineticsAbeer M Jabaiah, Jennifer A Getz, Witold A Witkowski, et al.
Plos One|November 22, 2013
A novel quantitative kinase assay using bacterial surface display and flow cytometrySónia Troeira Henriques, Louise Thorstholm, Yen-Hua Huang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 29, 2012
Site-specific targeting of antibody activity in vivo mediated by disease-associated proteasesOran Erster, Jerry M Thomas, Juliana Hamzah, et al.
Molecular & Cellular Proteomics : MCP|June 6, 2025
Soluble VCAM-1 May Serve as a Pharmacodynamic CSF Marker to Monitor BACE2 Activity in Non-Human PrimatesSarah K Tschirner, Y Joy Yu Zuchero, Jennifer A Getz, et al.
Toxicology and Applied Pharmacology|January 26, 2024
Nonclinical pharmacokinetics, pharmacodynamics and safety assessment of a FLT3L-Fc molecule for cancer immunotherapyKai Connie Wu, Adeyemi O Adedeji, Tanja S Zabka, et al.
Pageof 2